SMO Sarah Cannon Research Inst. is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.
SMO Sarah Cannon Research Inst. has participated in 7 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Breast Cancer.
Sponsors: Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SMO Sarah Cannon Research Inst. has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SMO Sarah Cannon Research Inst. has 7 clinical trials on record, with 1 currently active. Their work covers Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Breast Cancer.
SMO Sarah Cannon Research Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.